Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies.
about
Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine).Vipera ammodytes bites treated with antivenom ViperaTAb: a case series with pharmacokinetic evaluation.Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: an integrative review.PK/TD modeling for prediction of the effects of 8C2, an anti-topotecan mAb, on topotecan-induced toxicity in mice.Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease.Detection of venom after antivenom is not associated with persistent coagulopathy in a prospective cohort of Russell's viper (Daboia russelii) envenomingsSnake antivenoms.Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trialPopulation Pharmacokinetics of an Indian F(ab')2 Snake Antivenom in Patients with Russell's Viper (Daboia russelii) Bites.Assessing SABU (Serum Anti Bisa Ular), the sole Indonesian antivenom: A proteomic analysis and neutralization efficacy study.Biodistribution and Lymphatic Tracking of the Main Neurotoxin of Micrurus fulvius Venom by Molecular Imaging.Predicting the effects of 8C2, a monoclonal anti-topotecan antibody, on plasma and tissue disposition of topotecan.Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG.Crotalidae polyvalent immune Fab: in patients with North American crotaline envenomation.Antibody immunoprophylaxis and immunotherapy for influenza virus infection: utilization of monoclonal or polyclonal antibodies?A Single Dose of Viperfav(TM) May Be Inadequate for Vipera ammodytes Snake Bite: A Case Report and Pharmacokinetic EvaluationA novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.Snakebite: When the Human Touch Becomes a Bad Touch.Persistent pit viper envenomation in a cat.Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without β-propiolactone, in the treatment of Bothrops asper bites in Colombia
P2860
Q33380255-66758E9D-823C-466B-9643-4134D3DD115EQ33438472-5D4694CE-D0A8-41D2-A1F6-CD13CA3DA37BQ33471821-C8113383-BE5C-4DE7-8224-5549429FFB1BQ33896659-1ED2C2B9-9DD1-4076-B04A-2117D3215736Q34277605-4356D6CD-A1D7-4A02-BEB3-3D5AC940AF29Q34732689-7D862077-DECD-4FAF-BD70-840AE793A564Q35154674-A0C2BAB6-EEA8-4FC4-8CC9-FB89E11A831AQ35190068-6869264C-8C37-4DBF-9E85-B5019A847BE0Q35681038-F81FF777-85F6-4BAF-A319-2D39ADF83C73Q36199194-DC0C9451-E1AE-461C-9F7C-B751490D1D5DQ36846066-4E4269D1-CBE8-4659-97C7-DFEA29B8FF68Q37581834-6933EBC6-161E-4A64-B9D5-1CD2A3CE6D34Q37623149-C853A192-E541-4094-BFDE-84C13BC9EA8CQ37858511-9D7BEAC2-B945-4258-97EC-3B45CB805004Q40065071-1E478576-66A4-4C38-8428-C7F96A0305EAQ42331803-834A7515-89A0-4774-A930-4DE13602CC60Q45345427-41C78938-F877-47EE-B3A3-579E890F02A0Q52566029-90530730-C9C6-42D6-A6AE-B031A5F0C63CQ52796968-EA92A16C-879A-4C40-8C9B-B1B0A0B42904Q59290570-BA66777D-2C3E-4222-A5E3-24A22D90006C
P2860
Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Recurrence phenomena after imm ...... venoms and related antibodies.
@ast
Recurrence phenomena after imm ...... venoms and related antibodies.
@en
Recurrence phenomena after imm ...... venoms and related antibodies.
@nl
type
label
Recurrence phenomena after imm ...... venoms and related antibodies.
@ast
Recurrence phenomena after imm ...... venoms and related antibodies.
@en
Recurrence phenomena after imm ...... venoms and related antibodies.
@nl
prefLabel
Recurrence phenomena after imm ...... venoms and related antibodies.
@ast
Recurrence phenomena after imm ...... venoms and related antibodies.
@en
Recurrence phenomena after imm ...... venoms and related antibodies.
@nl
P356
P1476
Recurrence phenomena after imm ...... ivenoms and related antibodies
@en
P2093
P304
P356
10.1067/MEM.2001.113135
P407
P577
2001-02-01T00:00:00Z